Product Image

Omega-3 Orange Squeeze

Coromega
4.5
★ ★ ★ ★ ★
(429 ratings)
Omega-3 650 mg
EPA (Eicosapentaenoic Acid) 350 mg
Fish Oil 2000 mg
DHA 230 mg
Product Image
Score72
A portable, moderate-dose orange fish oil with named sources, but low concentration and limited quality-control detail.
How scoring works
Quantity:120 Packet(s) • (120 servings)
Goals:
Cardiovascular Support
Anti-Inflammatory Support
Skin Health
Vision Support

Score 72

A portable, moderate-dose orange fish oil with named sources, but low concentration and limited quality-control detail.
How scoring works
$49.99($0.41 per serving)
iHerb
$ 49.99
Report prices

Analysis

A packet provides 650 mg total omega-3s, including 350 mg EPA and 230 mg DHA, from 2,000 mg fish oil. The dose can support routine cardiovascular and skin goals, but the active concentration is low compared with more compact oils.

Anchovy and sardine sources are disclosed, and vitamin C is included. Molecular form, independent testing, antioxidant protection, and the full orange flavor system are not supplied.

Single packets are portable and avoid the need to swallow capsules. The format makes more sense for convenience-driven users than for shoppers seeking the most active omega-3 per serving.

Who is it for
  • Adults who prefer packets to capsules
  • People seeking a moderate portable omega-3 serving
Best for
  • Travel and on-the-go use
  • Moderate daily EPA and DHA intake

Pros

  • EPA and DHA are separately disclosed
  • Anchovy and sardine sources are named
  • Portable single-serving format

Cons

  • Only 650 mg omega-3s from 2,000 mg fish oil
  • Molecular form and purity testing are not shown
  • Complete flavor ingredients are absent

Warnings

  • Avoid with an allergy to anchovy, sardine, or other fish
  • EPA and DHA can add to anticoagulant or antiplatelet effects
  • Discard any packet that is swollen, leaking, or has a distinctly rancid smell

Nutrient quality

76 High impact

Named small-fish sources and clear fatty-acid amounts support basic quality. Low concentration and modest DHA constrain dose strength.

Ingredient transparency

71 High impact

Core fatty-acid quantities are visible and no proprietary blend hides the formula. Malformed entries, missing full directions, and undisclosed excipients substantially reduce clarity.

Customer satisfaction

64 Moderate impact

The supplied average rating is strong and the rating volume is moderate. No specific experience details were provided to judge repeated complaints or purpose alignment.

Value for money

75 High impact

The formula offers fair value for its cost. It remains moderately competitive but does not clearly lead the category.

Report analysis

Goals

Cardiovascular Support
Impact
Highest effect
A+ Goal FitB+ Strength of SupportC+ CoverageA+ Formula Quality
Fish Oil · 2000 mgVitamin C · 12 mg

The serving supplies 350 mg EPA and 230 mg DHA, directly supporting triglyceride management and vascular health. Fish oil has strong human evidence for cardiovascular risk markers.

The fully disclosed EPA and DHA amounts provide moderate depth in a focused omega-3 formula. The chemical form and independent oxidation testing are not provided, leaving some quality uncertainty.

Study evidence
Fish Oil Supportive 185 studies
Anti-Inflammatory Support
Impact
Highest effect
A Goal FitB+ Strength of SupportB- CoverageA+ Formula Quality
Fish Oil · 2000 mgVitamin C · 12 mg

EPA and DHA provide direct support for inflammatory signaling and inflammation resolution. The combined 580 mg amount is useful but more moderate than concentrated high-potency fish oils.

Clear EPA and DHA disclosure makes the active contribution easy to judge. A focused formula provides reasonable depth in one pathway without broader botanical or immune-nutrient coverage.

Study evidence
Fish Oil Supportive 68 studies
Skin Health
Impact
High effect
A- Goal FitB Strength of SupportC CoverageA Formula Quality
Vitamin C · 12 mgOmega-3 · 650 mg

EPA and DHA may support skin-barrier lipids and inflammatory balance. The serving lists 350 mg EPA and 230 mg DHA within 650 mg total omega-3 fatty acids.

Separate fatty-acid amounts are transparent, but molecular form, oxidation protection, and independent contaminant testing are not disclosed. The focused oil provides useful depth without collagen or antioxidant breadth.

Study evidence
Omega-3 Supportive 35 studies
Vision Support
Impact
High effect
B+ Goal FitC Strength of SupportC- CoverageA Formula Quality
Vitamin C · 12 mgEPA (Eicosapentaenoic Acid) · 350 mg

EPA and DHA provide relevant structural and ocular surface support, but the amounts are moderate rather than comprehensive. The formula lacks macular carotenoids and meaningful antioxidant coverage.

Individual fatty-acid amounts are clear, while molecular form, contaminant testing, and oil-protection details are missing. The anchovy and sardine sources make it unsuitable for people with a fish allergy.

Study evidence
Vitamin C Disputed 24 studies

Ingredients

IngredientAmount per serving
Calories
20 Calorie(s)
Total Fat
2 Gram(s)
Saturated Fat
0.5 Gram(s)
Cholesterol
10 mg
Vitamin C
12 mg
Fish Oil
2000 mg
Omega-3 Fatty Acids
650 mg
Eicosapentaenoic Acid
350 mg
Docosahexaenoic Acid
230 mg
Stevia Leaf Extract
10 mg
Gluten Free Adults 18–50 Dairy Free Children 4+
Report overview
Omega-3 · 650 mg OverallScore48
F Active Ingredient Quality & BioavailabilityC- Dose, Safety & Label TransparencyB+ Value

EPA and DHA are clearly disclosed from anchovy and sardine oil. Their combined amount is below half of the fish oil, and the molecular form, antioxidant protection, and independent purity testing are not shown. The low serving cost still provides competitive value per active gram.

F Active Ingredient Quality & BioavailabilityC Dose, Safety & Label TransparencyD+ Value

The serving provides 350 mg EPA, and epa exceeds dha by the preferred margin. EPA forms a small share of the fish oil, but the molecular form and contaminant-testing status are not disclosed. EPA cost efficiency is moderate, while no oil-protection antioxidant is listed.

Fish Oil · 2000 mg OverallScore31
F Active Ingredient Quality & BioavailabilityF Dose, Safety & Label TransparencyD+ Value

Anchovy and sardine provide clearly identified small-fish sources. EPA and DHA are fully disclosed, but their combined amount is low and represents less than one-third of the fish oil. Average active-omega-3 value is offset by missing molecular-form, purification, independent-testing, and antioxidant details.

Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Dietetic intervention in psoriatic arthritis: the DIETA trial.
    Leite BF; Morimoto MA; Gomes CMF; Klemz BNC; Genaro PS; Shivappa N; Hébert JR; Damasceno NRT; Pinheiro MM · Advances in rheumatology (London, England) · 2022
    Randomized trial97 participantsSkin Health forOmega-3
  2. Omega-3 fatty acid supplement skin cancer prophylaxis in lung transplant recipients: A randomized, controlled pilot trial.
    Miura K; Vail A; Chambers D; Hopkins PM; Ferguson L; Grant M; Rhodes LE; Green AC · The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 2019
    Randomized trial49 participantsSkin Health forOmega-3
  3. Allergic disease in infants up to 2 years of age in relation to plasma omega-3 fatty acids and maternal fish oil supplementation in pregnancy and lactation.
    Furuhjelm C; Warstedt K; Fagerås M; Fälth-Magnusson K; Larsson J; Fredriksson M; Duchén K · Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2011
    Randomized trial145 participantsSkin Health forOmega-3
  4. Dietary supplementation with very long-chain n-3 fatty acids in patients with atopic dermatitis. A double-blind, multicentre study.
    Søyland E; Funk J; Rajka G; Sandberg M; Thune P; Rustad L; Helland S; Middelfart K; Odu S; Falk ES · The British journal of dermatology · 1994
    Randomized trial145 participantsSkin Health forOmega-3
  5. Prenatal Omega-3 Supplementation and Eczema Risk among Offspring at Age 36 Months.
    Berman D; Clinton C; Limb R; Somers EC; Romero V; Mozurkewich E · Insights in allergy, asthma & bronchitis · 2020
    Randomized trial84 participantsSkin Health forOmega-3
  6. A systematic review of fish-oil supplements for the prevention and treatment of hypertension.
    Campbell F; Dickinson HO; Critchley JA; Ford GA; Bradburn M · European journal of preventive cardiology · 2013
    Meta-analysis1,524 participants17 studies pooledCardiovascular Support forFish Oil
  7. Impact of omega-3 fatty acids on hypertriglyceridemia, lipidomics, and gut microbiome in patients with type 2 diabetes.
    Lu J; Liu R; Ren H; Wang S; Hu C; Shi Z; Li M; Liu W; Wan Q; Su Q; Li Q; Zheng H; Qu S; Yang F; Ji H; Lin H; Qi H; Wu X; Wu K; Chen Y; Xu Y; Xu M; Wang T; Zheng J; Ning G; Zheng R; Bi Y; Zhong H; Wang W · Med (New York, N.Y.) · 2025
    Randomized trial309 participantsCardiovascular Support forFish Oil
  8. Vitamin D, Marine n-3 Fatty Acids, and Primary Prevention of Cardiovascular Disease Current Evidence.
    Manson JE; Bassuk SS; Cook NR; Lee IM; Mora S; Albert CM; Buring JE; VITAL Research Group · Circulation research · 2020
    Randomized trial25,871 participantsCardiovascular Support forFish Oil
  9. Marine n-3 fatty acid treatment for carotid plaques in patients with type 2 diabetes.
    Zhuang P; Liu X; Jia W; Zheng W; Wan X; Chen W; Gu J; Li Y; Lan X; Li H; Tong W; Wu Y; Wu X; Ao Y; Ye H; Wu F; Zhu L; Zhang L; Li Y; Meng D; Tian Y; Wang A; Wu S; Zhu F; Zhang Y; Shi H; Yu X; Zhang F; Zhang Y; Jiao J · Cardiovascular diabetology · 2026
    Randomized trial415 participantsCardiovascular Support forFish Oil
  10. Fish oil, enriched with polyunsaturated fatty acids of the omega-3-type accelerates the nucleation time in healthy subjects.
    Janowitz P; Swobodnik W; Wechsler JG; Janowitz A; Saal D; Ditschuneit H · Klinische Wochenschrift · 1991
    Non-randomized trial24 participantsCardiovascular Support forFish Oil
  11. Dose-dependent effects of fish oil on cardio-metabolic biomarkers in healthy middle-aged and elderly Chinese people: a double-blind randomized controlled trial.
    Song J; Hu M; Li C; Yang B; Ding Q; Wang C; Mao L · Food & function · 2018
    Randomized trial201 participantsAnti-Inflammatory Support forFish Oil
  12. Eicosapentaenoic acid supplementation alleviates pruritus, enhances skin moisture, and mitigates depression in maintenance hemodialysis patients.
    Lin YL; Wang CL; Chiang TI · Frontiers in nephrology · 2024
    Randomized trial60 participantsAnti-Inflammatory Support forFish Oil
  13. Lowering effects of fish oil supplementation on proinflammatory markers in hypertension: results from a randomized controlled trial.
    Yang B; Ren XL; Li ZH; Shi MQ; Ding F; Su KP; Guo XJ; Li D · Food & function · 2020
    Randomized trial77 participantsAnti-Inflammatory Support forFish Oil
  14. The effects of ω-3 fish oil emulsion-based parenteral nutrition plus combination treatment for acute paraquat poisoning.
    Meng Z; Dong Y; Gao H; Yao D; Gong Y; Meng Q; Zheng T; Cui X; Su X; Tian Y · The Journal of international medical research · 2019
    Randomized trial174 participantsAnti-Inflammatory Support forFish Oil
  15. Effects of Omega-3 Fatty Acid Intake in Patients Undergoing Dialysis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Liu R; Jiang J; Fu Z; Liu C; Yao L; Quan H · Journal of the American Nutrition Association · 2022
    Meta-analysis49 studies pooledAnti-Inflammatory Support forFish Oil
  16. Marine Omega-3 Supplementation and Cardiovascular Disease: An Updated Meta-Analysis of 13 Randomized Controlled Trials Involving 127 477 Participants.
    Hu Y; Hu FB; Manson JE · Journal of the American Heart Association · 2020
    Meta-analysis127,477 participants13 studies pooledCardiovascular Support forFish Oil
  17. Effects of fish oil-derived fatty acids on suboptimal cardiovascular health: A multicenter, randomized, double-blind, placebo-controlled trial.
    Zeng Q; Dong SY; Liu YP; Fu J; Shuai P; Zhao ZM; Li TX · Nutrition, metabolism, and cardiovascular diseases : NMCD · 2017
    Randomized trial422 participantsCardiovascular Support forFish Oil
  18. Effect of High-Dose Marine Omega-3 Fatty Acids on Atherosclerosis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.
    Sekikawa A; Cui C; Sugiyama D; Fabio A; Harris WS; Zhang X · Nutrients · 2020
    Meta-analysis6 studies pooledCardiovascular Support forFish Oil
  19. Clinical and metabolic response to flaxseed oil omega-3 fatty acids supplementation in patients with diabetic foot ulcer: A randomized, double-blind, placebo-controlled trial.
    Soleimani Z; Hashemdokht F; Bahmani F; Taghizadeh M; Memarzadeh MR; Asemi Z · Journal of diabetes and its complications · 2018
    Randomized trial60 participantsSkin Health forOmega-3
  20. Treatment of hard-to-heal wounds in ischaemic lower extremities with a novel fish skin-derived matrix.
    Lee YJ; Han HJ; Shim HS · Journal of wound care · 2024
    Randomized trial50 participantsSkin Health forOmega-3
  21. Effect of eicosapentaenoic acid, an omega-3 polyunsaturated fatty acid, on UVR-related cancer risk in humans. An assessment of early genotoxic markers.
    Rhodes LE; Shahbakhti H; Azurdia RM; Moison RM; Steenwinkel MJ; Homburg MI; Dean MP; McArdle F; Beijersbergen van Henegouwen GM; Epe B; Vink AA · Carcinogenesis · 2003
    Randomized trial42 participantsSkin Health forOmega-3
  22. Dietary omega-3 LCPUFA intake in the prevention of neovascular age-related macular degeneration: a systematic review and meta-analysis.
    Meng XT; Shi YY; Hong-Yan Z · Nutricion hospitalaria · 2022
    Meta-analysis5 studies pooledVision Support forEPA (Eicosapentaenoic Acid)
  23. Dietary omega-3 polyunsaturated fatty acids and fish intake and risk of age-related macular degeneration.
    Jiang H; Shi X; Fan Y; Wang D; Li B; Zhou J; Pei C; Ma L · Clinical nutrition (Edinburgh, Scotland) · 2022
    Meta-analysis21 studies pooledVision Support forEPA (Eicosapentaenoic Acid)
  24. Dietary fatty acid intake, plasma fatty acid levels, and the risk of age-related macular degeneration (AMD): a dose-response meta-analysis of prospective cohort studies.
    Zhong Y; Wang K; Jiang L; Wang J; Zhang X; Xu J; Yao K · European journal of nutrition · 2021
    Meta-analysis167,581 participants11 studies pooledVision Support forEPA (Eicosapentaenoic Acid)
  25. Dietary ω-3 fatty acid and fish intake and incident age-related macular degeneration in women.
    Christen WG; Schaumberg DA; Glynn RJ; Buring JE · Archives of ophthalmology (Chicago, Ill. : 1960) · 2011
    Cohort study38,022 participantsVision Support forEPA (Eicosapentaenoic Acid)
  26. Can Omega-3 Fatty Acids Serve as a Preventive Strategy for Age-Related Macular Degeneration? A Systematic Review and Meta-Analysis.
    Chen KY; Chan HC; Chan CM · The Journal of nutrition · 2026
    Meta-analysis18 studies pooledVision Support forEPA (Eicosapentaenoic Acid)
  27. Role of Oral Vitamin 'C' on Astigmatic Errors in Phacoemulsification.
    Mohan S; Sah K; Khattri M; Ahmad L; Sachan SK · Current eye research · 2021
    Randomized trial400 participantsVision Support forVitamin C
  28. Ascorbic acid metabolites are involved in intraocular pressure control in the general population.
    Hysi PG; Khawaja AP; Menni C; Tamraz B; Wareham N; Khaw KT; Foster PJ; Benet LZ; Spector TD; Hammond CJ · Redox biology · 2019
    Observational studyVision Support forVitamin C
  29. Nutritional modulation of cataract.
    Weikel KA; Garber C; Baburins A; Taylor A · Nutrition reviews · 2014
    Narrative reviewVision Support forVitamin C
  30. Dietary n-3 Fatty Acid, α-Tocopherol, Zinc, vitamin D, vitamin C, and β-carotene are Associated with Age-Related Macular Degeneration in Japan.
    Aoki A; Inoue M; Nguyen E; Obata R; Kadonosono K; Shinkai S; Hashimoto H; Sasaki S; Yanagi Y · Scientific reports · 2017
    Case-control study530 participantsVision Support forVitamin C
  31. Adherence to a Mediterranean diet, lifestyle and age-related macular degeneration: the Coimbra Eye Study - report 3.
    Raimundo M; Mira F; Cachulo MDL; Barreto P; Ribeiro L; Farinha C; Laíns I; Nunes S; Alves D; Figueira J; Merle BM; Delcourt C; Santos L; Silva R · Acta ophthalmologica · 2019
    Case-control study883 participantsVision Support forVitamin C